Canada Life’s TherapeuticsMD TXMD Stock Holding History

Canada Life’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-299	Closed	-$11K	–	2545
2021 Q3	$11K	Hold	299	–	–	﹤0.01%	2503
2021 Q2	$18K	Hold	299	–	–	﹤0.01%	2502
2021 Q1	$20K	Hold	299	–	–	﹤0.01%	2509
2020 Q4	$18K	Hold	299	–	–	﹤0.01%	2557
2020 Q3	$23K	Hold	299	–	–	﹤0.01%	2415
2020 Q2	$18K	Hold	299	–	–	﹤0.01%	2513
2020 Q1	$16K	Hold	299	–	–	﹤0.01%	2426
2019 Q4	$36K	Hold	299	–	–	﹤0.01%	2371
2019 Q3	$54K	Sell	299 -265	-47%	-$37.4K	﹤0.01%	1038
2019 Q2	$73K	Hold	564	–	–	﹤0.01%	2327
2019 Q1	$137K	Hold	564	–	–	﹤0.01%	1970
2018 Q4	$103K	Buy	564 +250	+80%	+$61K	﹤0.01%	2139
2018 Q3	$103K	Hold	314	–	–	﹤0.01%	2179
2018 Q2	$98K	Hold	314	–	–	﹤0.01%	2186
2018 Q1	$77K	Hold	314	–	–	﹤0.01%	2250
2017 Q4	$95K	Hold	314	–	–	﹤0.01%	2188
2017 Q3	$80K	Hold	314	–	–	﹤0.01%	2210
2017 Q2	$83K	Hold	314	–	–	﹤0.01%	2170
2017 Q1	$113K	Hold	314	–	–	﹤0.01%	2083
2016 Q4	$91K	Hold	314	–	–	﹤0.01%	2149
2016 Q3	$107K	Hold	314	–	–	﹤0.01%	2107
2016 Q2	$133K	Hold	314	–	–	﹤0.01%	2000
2016 Q1	$99K	Hold	314	–	–	﹤0.01%	1810
2015 Q4	$162K	Hold	314	–	–	﹤0.01%	1410
2015 Q3	$93K	Hold	314	–	–	﹤0.01%	1748
2015 Q2	$123K	Buy	+314	New	+$111K	﹤0.01%	1716

Other funds holding TXMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Canada Life's TXMD Position: Q4 2021 in Review

Canada Life sold out of TherapeuticsMD (TXMD) in Q4 2021, closing a stake of 299 shares — an estimated $11K sold.

Canada Life first reported a position in TXMD in Q2 2015 and held it in 26 quarters. The position peaked at $162K in Q4 2015. 131 funds tracked by Wall St. Rank hold TXMD as of Q4 2021.

Canada Life reported no remaining TherapeuticsMD position as of Q4 2021 after selling out during the quarter.
Canada Life sold 299 TherapeuticsMD shares in Q4 2021, an estimated $11K.
Canada Life first reported a position in TherapeuticsMD in Q2 2015 and held it in 26 quarters.
Canada Life's TherapeuticsMD position peaked at $162K in Q4 2015.
131 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2021.

Based on Canada Life's 13F filing for Q4 2021, filed 14 Feb 2022.